Αποτελέσματα Αναζήτησης
23 Ιαν 2023 · Communicate the importance of collaboration and coordination among the interprofessional team, which can enhance patient care when dosing and monitoring anticoagulant drugs and improve patient outcomes for patients receiving anticoagulation undergoing non-cardiac elective surgery.
BRILINTA. What are the Indications for TICAGRELOR? 1 INDICATIONS AND USAGE • BRILINTA is a P2Y 12 platelet inhibitor indicated • to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI.
BRILINTA is indicated to reduce the risk of cardiovascular death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. For at least the first 12 months following ACS, it is superior to clopidogrel.
BRILINTA is indicated to reduce the risk of cardiovascular death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. For at least the first 12 months following ACS, it is superior to clopidogrel.
30 Αυγ 2017 · Guideline for Preoperative Medication Management. Purpose of Guideline: To provide guidance to physicians, advanced practice providers (APPs), pharmacists, and nurses regarding medication management in the preoperative setting.
In patients with acute ischemic stroke or high-risk TIA, initiate treatment with a 180-mg loading dose of BRILINTA and then continue with 90 mg twice daily for up to 30 days. Use BRILINTA with a loading dose of aspirin (300 mg to 325 mg) and a daily maintenance dose of aspirin of 75 mg to 100 mg.
1 Δεκ 2013 · Several factors need to be considered before a decision to continue or stop antiplatelet agents perioperatively. An important factor is the initial indication for antiplatelet therapy and, most importantly, the consequences of stopping the drug before the operation.
